恩替卡韦长期抗病毒治疗对老年慢性乙型肝炎患者肾功能的影响

L. Liang, Hongyi Li, Jiang-bo Ren, Min Wang, Guanhuan Zhang, Yu Wang
{"title":"恩替卡韦长期抗病毒治疗对老年慢性乙型肝炎患者肾功能的影响","authors":"L. Liang, Hongyi Li, Jiang-bo Ren, Min Wang, Guanhuan Zhang, Yu Wang","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.11.016","DOIUrl":null,"url":null,"abstract":"Objective \nTo evaluate the impact of long-term treatment with Entecavir(ETV)on renal function in elderly patients with chronic hepatitis B(CHB). \n \n \nMethods \nElderly patients with CHB receiving ETV(0.5 mg/d)antiviral therapy who were followed up for 234 weeks in Beijing Friendship Hospital were retrospective analyzed.The estimated glomerular filtration rate(eGFR)(CKD-EPI creatinine formula)was used to evaluate renal function changes at baseline and 52, 104, 156, 208 and 234 weeks after treatment. \n \n \nResults \nA total of 40 included patients with CHB aged 60-81 years were enrolled, with baseline eGFR value(n=40) of (64.25±11.32)ml·min-1·1.73 m-2.The eGFR values at all time points after treatment were as following: (63.85±11.53)ml·min-1·1.73 m-2, (63.71±11.58)ml·min-1·1.73 m-2, (59.95±9.59)ml·min-1·1.73 m-2, (62.28±15.32)ml·min-1·1.73 m-2, (65.78±15.99)ml·min-1·1.73 m-2 at 52 weeks(40 cases), 104 weeks(40 cases), 156 weeks(38 cases), 208 weeks(36 cases)and 234 weeks(28 cases)after ETV treatment respectively.And the difference of eGFR values among all time points was not statistically significant(F=0.291, P=0.072). The results of the pairwise comparison showed that as compared with the baseline eGFR value, the eGFR values had no statistically significant difference at all time points after treatment(P>0.05). The baseline creatinine value in all 40 patients was(57.23±9.67)μmol/L.Creatinine values at 52 weeks(15 cases), 104 weeks(5 cases), 156 weeks(6 cases), 208 weeks(8 cases)and 234 weeks(6 cases)after ETV treatment, were(63.78±8.63)μmol/L, (67.86±11.21)μmol/L, (71.46±13.75)μmol/L, (68.22±8.99)μmol/L and(79.53±9.58)μmol/L respectively, with no significant difference(F=0.266, P=0.067). The results of the pairwise comparison showed that as compared with the baseline creatinine value, the creatinine values had no significant difference at all time points after ETV treatment(P>0.05). \n \n \nConclusions \nETV treatment has no effect on renal function in elderly patients with chronic hepatitis B. \n \n \nKey words: \nHepatitis B, chronic; Antiviral agents; Renal function","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1258-1261"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of long-term antiviral therapy with Entecavir on renal function in elderly patients with chronic hepatitis B\",\"authors\":\"L. Liang, Hongyi Li, Jiang-bo Ren, Min Wang, Guanhuan Zhang, Yu Wang\",\"doi\":\"10.3760/CMA.J.ISSN.0254-9026.2019.11.016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo evaluate the impact of long-term treatment with Entecavir(ETV)on renal function in elderly patients with chronic hepatitis B(CHB). \\n \\n \\nMethods \\nElderly patients with CHB receiving ETV(0.5 mg/d)antiviral therapy who were followed up for 234 weeks in Beijing Friendship Hospital were retrospective analyzed.The estimated glomerular filtration rate(eGFR)(CKD-EPI creatinine formula)was used to evaluate renal function changes at baseline and 52, 104, 156, 208 and 234 weeks after treatment. \\n \\n \\nResults \\nA total of 40 included patients with CHB aged 60-81 years were enrolled, with baseline eGFR value(n=40) of (64.25±11.32)ml·min-1·1.73 m-2.The eGFR values at all time points after treatment were as following: (63.85±11.53)ml·min-1·1.73 m-2, (63.71±11.58)ml·min-1·1.73 m-2, (59.95±9.59)ml·min-1·1.73 m-2, (62.28±15.32)ml·min-1·1.73 m-2, (65.78±15.99)ml·min-1·1.73 m-2 at 52 weeks(40 cases), 104 weeks(40 cases), 156 weeks(38 cases), 208 weeks(36 cases)and 234 weeks(28 cases)after ETV treatment respectively.And the difference of eGFR values among all time points was not statistically significant(F=0.291, P=0.072). The results of the pairwise comparison showed that as compared with the baseline eGFR value, the eGFR values had no statistically significant difference at all time points after treatment(P>0.05). The baseline creatinine value in all 40 patients was(57.23±9.67)μmol/L.Creatinine values at 52 weeks(15 cases), 104 weeks(5 cases), 156 weeks(6 cases), 208 weeks(8 cases)and 234 weeks(6 cases)after ETV treatment, were(63.78±8.63)μmol/L, (67.86±11.21)μmol/L, (71.46±13.75)μmol/L, (68.22±8.99)μmol/L and(79.53±9.58)μmol/L respectively, with no significant difference(F=0.266, P=0.067). The results of the pairwise comparison showed that as compared with the baseline creatinine value, the creatinine values had no significant difference at all time points after ETV treatment(P>0.05). \\n \\n \\nConclusions \\nETV treatment has no effect on renal function in elderly patients with chronic hepatitis B. \\n \\n \\nKey words: \\nHepatitis B, chronic; Antiviral agents; Renal function\",\"PeriodicalId\":9997,\"journal\":{\"name\":\"中华老年医学杂志\",\"volume\":\"38 1\",\"pages\":\"1258-1261\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华老年医学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.11.016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华老年医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.11.016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的评价恩替卡韦(ETV)长期治疗对老年慢性乙型肝炎(CHB)患者肾功能的影响。方法对在北京友谊医院接受ETV(0.5mg/d)抗病毒治疗234周的老年慢性乙型肝炎患者进行回顾性分析。估计肾小球滤过率(eGFR)(CKD-EPI肌酸酐公式)用于评估基线和治疗后52、104、156、208和234周的肾功能变化。结果纳入40例60~81岁慢性乙型肝炎患者,基线eGFR值(n=40)为(64.25±11.32)ml·min-1·1.73m-2。治疗后各时间点的eGFR分别为:(63.85±11.53)ml·min-1·1.73m-2、,ETV治疗后52周(40例)、104周(40例行)、156周(38例行)、208周(36例行)和234周(28例行)分别为(65.78±15.99)ml·min-1·1.73m-2。各时间点间eGFR值差异无统计学意义(F=0.291、P=0.072)。配对比较结果表明,40例患者的基线肌酸酐值为(57.23±9.67)μmol/L。ETV治疗后52周(15例)、104周(5例)、156周(6例)、208周(8例)和234周(6例行)的肌酸酐值分别为(63.78±8.63)μmol/L、(67.86±11.21)μmol/L和(71.46±13.75)μmol/L,(68.22±8.99)μmol/L和(79.53±9.58)μmol/L,差异无统计学意义(F=0.266,P=0.067),结论ETV治疗对老年慢性乙型肝炎患者肾功能无影响。关键词:乙型肝炎,慢性;抗病毒药物;肾功能
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Impact of long-term antiviral therapy with Entecavir on renal function in elderly patients with chronic hepatitis B
Objective To evaluate the impact of long-term treatment with Entecavir(ETV)on renal function in elderly patients with chronic hepatitis B(CHB). Methods Elderly patients with CHB receiving ETV(0.5 mg/d)antiviral therapy who were followed up for 234 weeks in Beijing Friendship Hospital were retrospective analyzed.The estimated glomerular filtration rate(eGFR)(CKD-EPI creatinine formula)was used to evaluate renal function changes at baseline and 52, 104, 156, 208 and 234 weeks after treatment. Results A total of 40 included patients with CHB aged 60-81 years were enrolled, with baseline eGFR value(n=40) of (64.25±11.32)ml·min-1·1.73 m-2.The eGFR values at all time points after treatment were as following: (63.85±11.53)ml·min-1·1.73 m-2, (63.71±11.58)ml·min-1·1.73 m-2, (59.95±9.59)ml·min-1·1.73 m-2, (62.28±15.32)ml·min-1·1.73 m-2, (65.78±15.99)ml·min-1·1.73 m-2 at 52 weeks(40 cases), 104 weeks(40 cases), 156 weeks(38 cases), 208 weeks(36 cases)and 234 weeks(28 cases)after ETV treatment respectively.And the difference of eGFR values among all time points was not statistically significant(F=0.291, P=0.072). The results of the pairwise comparison showed that as compared with the baseline eGFR value, the eGFR values had no statistically significant difference at all time points after treatment(P>0.05). The baseline creatinine value in all 40 patients was(57.23±9.67)μmol/L.Creatinine values at 52 weeks(15 cases), 104 weeks(5 cases), 156 weeks(6 cases), 208 weeks(8 cases)and 234 weeks(6 cases)after ETV treatment, were(63.78±8.63)μmol/L, (67.86±11.21)μmol/L, (71.46±13.75)μmol/L, (68.22±8.99)μmol/L and(79.53±9.58)μmol/L respectively, with no significant difference(F=0.266, P=0.067). The results of the pairwise comparison showed that as compared with the baseline creatinine value, the creatinine values had no significant difference at all time points after ETV treatment(P>0.05). Conclusions ETV treatment has no effect on renal function in elderly patients with chronic hepatitis B. Key words: Hepatitis B, chronic; Antiviral agents; Renal function
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
8523
期刊介绍:
期刊最新文献
Key points for the prevention and treatment of the novel coronavirus pneumonia in the elderly Analysis of difference in oral bacteria flora in saliva among elderly people in longevity zone of Guangxi Progress in research on venous thromboembolism in elderly patients with lung cancer Clinical significance of the monocyte to high-density lipoprotein cholesterol ratio in the assessment of imperfect ST-segment resolution in elderly patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention Analysis of bone mineral density and bone metabolism in elderly hip fracture patients of different genders
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1